相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

通过向三阴性乳腺癌的代谢变化诱导铁亡

Yaru Wang¹, Yue Sun¹, Feiran Wang¹

¹The Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|November 11, 2023

概括

铁亡,一种涉及铁和脂质的细胞死亡过程,显示出治疗三阴性乳腺癌 (TNBC) 的前景. 了解其代谢联系可以在TNBC治疗中克服药物耐药性.

科学领域:

生物化学生物化学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性恶性瘤.
铁亡,一种独特的编程细胞死亡形式,以铁的积累和脂质过氧化为特征.
TNBC瘤具有高铁和脂质含量,使其易受铁灭诱导的影响.

研究的目的:

审查最近关于铁死在TNBC中的作用的进展.
探索铁和氨基酸,铁和TNBC中的脂质代谢之间的复杂联系.
讨论铁化作为TNBC的潜在治疗点.

主要方法:

关于铁亡,新陈代谢和TNBC的研究的文献综述.
分析影响铁灭敏感性的代谢途径.
对TNBC的铁致死向疗法进行当前研究的综合.

主要成果:

铁灭诱导是TNBC治疗的可行策略,原因是瘤特异性的代谢脆弱性.
癌细胞的代谢适应性可以被利用来启动铁亡并对抗药物耐药性.
氨基酸,铁和脂质代谢的失调显著影响TNBC中的铁化.

结论:

铁化代表了新型TNBC治疗的有希望的途径,包括化疗,放射治疗,免疫治疗,纳米治疗和天然产品治疗.
准参与铁亡的代谢途径为改善TNBC的临床结果提供了新的视角.
需要进一步的研究,以充分阐明TNBC中铁亡的机制,并优化其治疗应用.

关键词:

铁化是铁化的一种.代谢重编程是一种代谢重编程.治疗疗法治疗疗法三重阴性乳腺癌 (TNBC) 是一种

更多相关视频

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

相关概念视频

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...